To access this element change to forms mode OFF
Grant Award View - GA271308
P. vivax Serological Testing & Treatment: a novel intervention to...
GA ID:
GA271308
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Sep-2022
Publish Date:
31-Oct-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2027
Value (AUD):
$2,474,656.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
P. vivax Serological Testing & Treatment: a novel intervention to facilitate malaria elimination
Purpose:
This research program aims to develop the diagnostic tools and clinical trials evidence to prove that a new public health intervention, P. vivax Serological Test and Treat (SeroTAT) can facilitate PV elimination in vivax endemic countries world-wide. To achieve this, we will develop a new class of malaria point-of-care sero-diagnostic test that can identify those most at risk of recurrent vivax malaria, and prove that treating these people will significantly reduce P. vivax transmission.
GO ID:
GO Title:
Investigator Grants 2022
InternalReferenceId:
2022/GNT2016726
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA